SCHEMBL17562016

SCHEMBL17562016

CCn1c2c(c3c1CCC=C3)CC(N)C=C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1755406 0.74 — —
SCHEMBL16229867 0.67 KDM4E (0.43) —
SCHEMBL24772860 0.65 — —
SCHEMBL19549042 0.63 RAB9A (0.45) —
SCHEMBL24385276 0.63 — —
SCHEMBL23838379 0.60 KDM4E (0.49) —
SCHEMBL24714237 0.60 KDM4E (0.32) —
SCHEMBL24268934 0.59 — —
SCHEMBL14781275 0.58 GRIN2D (0.38) —
SCHEMBL15149266 0.57 ALDH1A1 (0.55) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278956-B1 Small-molecule inhibitors of Rac1 in metastatic cancer cells UNIVERSITY OF PUERTO RICO (US) 2016-03-08 — — US disclosed
Send feedback